yonderboy wrote:
Tfau,
After reading your post (above), I reread the original Buffalo study release, they say that "...The first 500 patients, both adults and children, were grouped based on their diagnosis: MS, clinically isolated syndrome (CIS) and "other neurologic diseases" (OND), in addition to healthy
controls..." Nowhere do they state that the CIS patients are included in the 55% number.
I then tried to read all of the releases reported today. It appears that only the Canadian press has printed the very exciting statement that "...The researchers also found fewer cases of CCSVI in patients who had experienced a single MS attack, called clinically isolated syndrome, compared to those with more advanced symptoms of the disease -38 per cent versus about 80 per cent..."
I agree that this would be earth shattering news, but unfortunately I think its just bad reporting because - using the information in the Buffalo release - that 280 of the 500 subjects had MS, and assuming that somehow the CIS subjects were included in the 280: in order to get from 55% with CCSVI to 80%, you have to assume that 167 of the 280 MS subjects actually only had CIS.
That just doesn't make sense to me - I hope I'm wrong.
This was my interpretation ,
We actually don't know the # of people in each group. So when they say 38 % of the CIS had ccsvi. Well how many did they originally scan? they aren't saying.
Take 80 + 38 / 2 and the average is 59 %, take off a few percent for other neurological dieseases and your right around 56%
I could be wrong, but it seems to me they are just lumping all the MS groups together. Which gives a average of 55%.
hey it makes sense to me
